In Focus: Due Diligence
Posted 01 July 2009 | By
This month we venture into the business side of regulatory with an issue concentrating on due diligence. Due diligence is usually thought of as an investigation of facts about a company or product by a concerned party, often a potential buyer. In the regulatory context, we would normally expect to see due diligence conducted as part of the acquisition of a company or product line. Particularly in the drug world, the regulatory status of products can be a deciding factor in a sale or merger. However, due diligence could also be internal: confirmation by management or others that certain regulatory steps have been taken, or that products are properly licensed and procedures correctly dealt with.